Share-based Payment Arrangement, Expense of ROCKWELL MEDICAL, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ROCKWELL MEDICAL, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • ROCKWELL MEDICAL, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $532,000, a 66% increase year-over-year.
  • ROCKWELL MEDICAL, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,741,000, a 54% increase year-over-year.
  • ROCKWELL MEDICAL, INC. annual Share-based Payment Arrangement, Expense for 2024 was $1,292,000, a 39% increase from 2023.
  • ROCKWELL MEDICAL, INC. annual Share-based Payment Arrangement, Expense for 2023 was $932,000, a 196% increase from 2022.
  • ROCKWELL MEDICAL, INC. annual Share-based Payment Arrangement, Expense for 2022 was $315,000, a 67% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ROCKWELL MEDICAL, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,741,000 $532,000 +$211,000 +66% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,530,000 $382,000 +$44,000 +13% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,486,000 $445,000 +$194,000 +77% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,292,000 $382,000 +$164,000 +75% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $1,128,000 $321,000 +$109,000 +51% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,019,000 $338,000 +$29,000 +9.4% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $990,000 $251,000 +$58,000 +30% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $932,000 $218,000 -$2,000 -0.91% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $934,000 $212,000 +$36,000 +20% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $898,000 $309,000 +$211,000 +215% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $687,000 $193,000 +$372,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $315,000 $220,000 -$165,000 -43% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $480,000 $176,000 -$185,000 -51% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $665,000 $98,000 -$335,000 -77% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $1,000,000 $179,000 +$57,000 +24% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $943,000 $385,000 -$366,000 -49% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,309,000 $361,000 +$111,000 +44% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,198,000 $433,000 +$1,894,000 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $696,000 $236,000 -$1,171,000 -125% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $475,000 $751,000 -$305,372 -29% 01 Oct 2020 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q3 2020 $780,372 $250,000 -$627,000 -71% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $1,407,372 $1,461,000 -$2,962,326 -197% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $4,369,698 $935,000 -$582,302 -38% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $4,952,000 $1,056,372 -$905,264 -46% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $5,857,264 $877,000 +$262,417 +43% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $5,594,847 $1,501,326 +$135,994 +10% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $5,458,853 $1,517,302 +$1,071,299 +240% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $4,387,554 $1,961,636 01 Oct 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
Q3 2018 $614,583 -$1,021,924 -62% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,365,332 -$746,354 -35% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $446,003 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q3 2017 $1,636,507 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $2,111,686 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2

ROCKWELL MEDICAL, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,292,000 +$360,000 +39% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $932,000 +$617,000 +196% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $315,000 -$628,000 -67% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $943,000 +$468,000 +99% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $475,000 -$4,477,000 -90% 01 Jan 2020 31 Dec 2020 10-K 08 Apr 2022 2021 FY
2019 $4,952,000 +$564,446 +13% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $4,387,554 -$2,787,042 -39% 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
2017 $7,174,596 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
2014 $4,597,412 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.